Kintara Therapeutics, Inc. (KTRA) Social Stream
KINTARA THERAPEUTICS INC (KTRA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KTRA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-16 | 3 | $6 | $3 | $4.562 | $0.141 | 3135.46% |
| 2021-12-02 | 3 | $6 | $3 | $4.75 | $0.141 | 3268.79% |
| 2022-02-14 | 2 | $250 | $250 | $250 | $0.141 | 177204.96% |
| 2022-03-18 | 3 | $5 | $3 | $4 | $0.141 | 2736.88% |
| 2022-04-08 | 2 | $5 | $1.5 | $3.25 | $0.141 | 2204.96% |
| 2022-04-12 | 2 | $5 | $1.5 | $3.166 | $0.141 | 2145.39% |
| 2023-09-08 | 2 | $14 | $14 | $14 | $0.141 | 9829.08% |
| NA | 2 | $NA | $NA | $NA | $0.141 | NA% |
The Trend in the Analyst Price Target
Over the past 31 months, KTRA's average price target has gone up $8.5.
Over the past 56 days, KTRA's average upside potential has been 209.37%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-07-14 | 2 | 14 | 14 | 14 | 4.64 | 201.72% |
| 2023-07-21 | 2 | 14 | 14 | 14 | 4.47 | 213.2% |
| 2023-09-08 | 2 | 14 | 14 | 14 | 4.47 | 213.2% |
KTRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
KTRA's average broker recommendation rating worsened by 1.33 over the prior 19 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- KINTARA THERAPEUTICS INC's number of analysts covering the stock is higher than 56.49% of all US stocks.
- KINTARA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1092.57% of all US stocks.
- In the context of Healthcare stocks, KINTARA THERAPEUTICS INC's average analyst price target is greater than 157.65% of them.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, KINTARA THERAPEUTICS INC's variance in analysts' estimates is lower than -546.89% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KINTARA THERAPEUTICS INC are ATXI, LPTX, and PULM.
View All Top Stocks by Price Target
Make investment decisions regarding KTRA using the data that counts. Try POWR Ratings for free.